Correlation between magnetic resonance images of peritumor margin enhancement and prognosis in hepatocellular carcinoma after drug-eluting bead transcatheter arterial chemoembolization

被引:0
|
作者
Kuang, Donglin [1 ]
Zhang, Nan [1 ]
Zhang, Mengfan [1 ]
Li, Hao [1 ]
Han, Xinwei [1 ]
Ren, Jianzhuang [1 ]
Duan, Xuhua [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Intervent Radiol, Zhengzhou, Henan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; drug-eluting bead transcatheter arterial chemoembolization; magnetic resonance imaging; margin enhancement; morphology; MICROVASCULAR INVASION; TRANSARTERIAL CHEMOEMBOLIZATION; HEPATIC-TUMORS; ABLATION; CT; MR; MICROSPHERES; PREDICTION; SURVIVAL; CANCER;
D O I
10.3389/fonc.2023.957710
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThe aim of this study is to investigate the morphological characteristics and clinical significance of magnetic resonance (MR) images of peritumor margin enhancement in hepatocellular carcinoma (HCC) after drug-eluting bead transcatheter arterial chemoembolization (DEB-TACE). MethodsFrom January 2017 to December 2020, a total of 162 patients who received a diagnosis of HCC were included in our study. We began the follow-up with magnetic resonance imaging (MRI) for complete response assessment, and peritumor margin enhancements were classified as sharp and rough types according to morphology. During the follow-up, data such as progression or remission of the two enhancement modalities, morphological changes in terms of margin enhancements observed in MR images, and alpha-fetoprotein (AFP) levels were recorded. ResultsIn the follow-up period of 36 months, 70 and 92 patients with sharp- and rough-type peritumor margins, respectively, were observed. At the end of the follow-up, patients with sharp-type margins had lower AFP levels and longer progression-free survival than those with rough-type margins (P < 0.05). Furthermore, the sharp-type margin was thinner than the rough-type margin (all P < 0.05). Moreover, the sharp-type group had a high incidence of tumors with a diameter of < 5 cm, whereas the rough-type group had a high incidence of tumors with a diameter of >= 5 cm. Continuous enhancements of peritumor margins in MRI were greater in the sharp-type group than in the rough-type group. Most of the patients with a sharp-type margin achieved disease remission (94.3%, P < 0.05), whereas most of those with a rough-type margin experienced disease progression (84.8%, P < 0.05). ConclusionsPatients with HCC with a sharp-type margin enhancement on MRI after DEB-TACE mostly demonstrated benign lesions with a good prognosis, whereas those with a rough-type margin mostly demonstrated malignant growth.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Does Drug-Eluting Bead Transcatheter Arterial Chemoembolization Improve the Management of Patients with Hepatocellular Carcinoma? A Meta-Analysis
    Han, Shilong
    Zhang, Xiaoping
    Zou, Liling
    Lu, Chenhui
    Zhang, Jun
    Li, Jue
    Li, Maoquan
    PLOS ONE, 2014, 9 (08):
  • [2] Initial Experience of Drug-Eluting Bead-Transcatheter Arterial Chemoembolization After Lipiodol-Based Transcatheter Arterial Chemoembolization Failure for Patients with Advanced Hepatocellular Carcinoma
    Liu, Kai-Cai
    Lv, Wei-Fu
    Lu, Dong
    Hou, Chang-Long
    Xie, Jun
    Lu, Yu-He
    Cao, Qi-Sheng
    Tan, Yu-Lin
    Zhang, Ying-Zhan
    Liu, Jie
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 7973 - 7980
  • [3] MRI Findings and Prediction of Time to Progression of Patients with Hepatocellular Carcinoma Treated with Drug-eluting Bead Transcatheter Arterial Chemoembolization
    Lee, Seungsoo
    Kim, Kyung Ah
    Park, Mi-Suk
    Choi, Sun Young
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (07) : 965 - 973
  • [4] Tumor Enhancement and Heterogeneity Are Associated With Treatment Response to Drug-Eluting Bead Chemoembolization for Hepatocellular Carcinoma
    Reis, Stephen P.
    Sutphin, Patrick D.
    Singal, Amit G.
    Grzybowski, Richard
    Fisher, Stephen
    Ball, Christopher
    Xi, Yin
    Grewal, Simer
    Kalva, Sanjeeva P.
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2017, 41 (02) : 289 - 293
  • [5] Drug-eluting Bead-Transcatheter Arterial Chemoembolization for Advanced Hepatocellular Carcinoma Refractory to Conventional Lipiodol-based Transcatheter Arterial Chemoembolization
    Kobayashi, Saito
    Tajiri, Kazuto
    Murayama, Aiko
    Entani, Toshiki
    Futsukaichi, Yuka
    Nagata, Kohei
    Takahashi, Kosuke
    Yasuda, Ichiro
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2020, 7 : 181 - 189
  • [6] Enhancement Patterns of Hepatocellular Carcinoma After Transarterial Chemoembolization Using Drug-Eluting Beads on Arterial Phase CT Images: A Pilot Retrospective Study
    Chung, Woo-Suk
    Lee, Kwang-Hun
    Park, Mi-Suk
    Lee, Yeo Jin
    Kwon, Joonho
    Baek, Song-Ee
    Kim, Myeong-Jin
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (02) : 349 - 359
  • [7] Nanosized drug-eluting bead for transcatheter arterial chemoembolization (ND-TACE)
    Zhao, Jun
    Li, Yan-shu
    Liu, Zhi-Xing
    Huang, Mu-Hua
    Xu, Yu-hua
    Liang, Qing-rong
    Chen, Li
    Luo, Rong-guang
    Tang, Qun
    JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (37) : 8684 - 8694
  • [8] Delayed Intratumoral Hemorrhage after Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma
    Shiozawa, Kazue
    Watanabe, Manabu
    Ikehara, Takashi
    Ogino, Yu
    Umakoshi, Tomoko
    Matsukiyo, Yasushi
    Kogame, Michio
    Matsui, Teppei
    Kikuchi, Yoshinori
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    CASE REPORTS IN ONCOLOGY, 2014, 7 (03): : 739 - 745
  • [9] Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
    Liu, Yi-Sheng
    Lin, Chia-Ying
    Chuang, Ming-Tsung
    Tsai, Yi-Shan
    Wang, Chien-Kuo
    Ou, Ming-Ching
    BMC GASTROENTEROLOGY, 2018, 18
  • [10] Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization
    Gorodetski, Boris
    Chapiro, Julius
    Schernthaner, Ruediger
    Duran, Rafael
    Lin, MingDe
    Lee, Howard
    Lenis, David
    Stuart, Elizabeth A.
    Nonyane, Bareng Aletta Sanny
    Pekurovsky, Vasily
    Tamrazi, Anobel
    Gebauer, Bernhard
    Schlachter, Todd
    Pawlik, Timothy M.
    Geschwind, Jean-Francois
    EUROPEAN RADIOLOGY, 2017, 27 (02) : 526 - 535